Delisting riskEarnings are out
Immutep (ADR) (IMMP)
Develops LAG-3 immunotherapies for cancer and autoimmune disease.
$0.3701
Pre-market−0.01 (−3.34%)
At close$0.3829(+3.15%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Feb '23Sep '23Apr '24Aug '24Feb '25Aug '25Feb '26Aug '26
Reported−$0.02−$0.01−$0.01−$0.01−$0.01−$0.18−$0.22−$0.17
Estimate−$0.08−$0.09−$0.09−$0.08−$0.08−$0.12−$0.20−$0.03
Surprise+80.8%+84.8%+86.1%+86.1%+88.7%−44.0%−9.9%−550.0%
RevenueReportedEstimate
Feb '23Sep '23Apr '24Aug '24Feb '25Aug '25Feb '26Aug '26
Reported$1.2M$1.2M$1.4M$1.2M$1.9M$1.2M$5.5M$10.0M
Estimate—$1.4M$1.2M$1.2M$433.2K—$9.4M$11.7M
Surprise—−14.4%+19.6%−6.6%+349.7%—−41.5%−15.0%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.03 | −$0.17 | −550.0% |
| Feb 2026 | −$0.20 | −$0.22 | −9.9% |
| Aug 2025 | −$0.12 | −$0.18 | −44.0% |
| Feb 2025 | −$0.08 | −$0.01 | +88.7% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Sep 2023 | |||
| Feb 2023 | |||
| Jul 2022 | |||
| Feb 2022 | |||
| Aug 2021 | |||
| Feb 2021 | |||
| Aug 2020 | |||
| Feb 2020 | |||
| Aug 2019 | |||
| Feb 2019 | |||
| Aug 2018 | |||
| Feb 2018 | |||
| Aug 2017 | |||
| Feb 2017 | |||
| Aug 2016 | |||
| Feb 2016 | |||
| Aug 2015 | |||
| Feb 2015 | |||
| Sep 2014 | |||
| Feb 2014 | |||
| Oct 2013 | |||
| Feb 2013 | |||
| Oct 2012 | |||
| Dec 2011 | |||
| Jun 2011 | |||
| Dec 2010 | |||
| Jun 2010 | |||
| Dec 2009 | |||
| Jun 2009 | |||
| Dec 2008 | |||
| Jun 2008 | |||
| Dec 2007 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 30, 2026 | −$0.03 | −$0.17 | −550.0% | $11.7M | $10.0M | −15.0% | −3.9% |
| Feb 24, 2026 | −$0.20 | −$0.22 | −9.9% | $9.4M | $5.5M | −41.5% | −0.4% |
| Aug 28, 2025 | −$0.12 | −$0.18 | −44.0% | — | $1.2M | — | −3.0% |
| Feb 26, 2025 | −$0.08 | −$0.01 | +88.7% | $433.2K | $1.9M | +349.7% | 0.0% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||||||
| Aug 30, 2024 | |||||||
| Apr 29, 2024 | |||||||
| Sep 28, 2023 | |||||||
| Feb 24, 2023 | |||||||
| Jul 28, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Aug 30, 2021 | |||||||
| Feb 23, 2021 | |||||||
| Aug 25, 2020 | |||||||
| Feb 24, 2020 | |||||||
| Aug 20, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Aug 21, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Aug 28, 2017 | |||||||
| Feb 24, 2017 | |||||||
| Aug 31, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Aug 28, 2015 | |||||||
| Feb 27, 2015 | |||||||
| Sep 24, 2014 | |||||||
| Feb 18, 2014 | |||||||
| Oct 30, 2013 | |||||||
| Feb 25, 2013 | |||||||
| Oct 3, 2012 | |||||||
| Dec 30, 2011 | |||||||
| Jun 30, 2011 | |||||||
| Dec 30, 2010 | |||||||
| Jun 30, 2010 | |||||||
| Dec 30, 2009 | |||||||
| Jun 30, 2009 | |||||||
| Dec 30, 2008 | |||||||
| Jun 30, 2008 | |||||||
| Dec 30, 2007 | |||||||